According to the latest report by IMARC Group “Biological Safety Cabinet Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global biological safety cabinet market size reached US$ 207 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 320.5 Million by 2027, exhibiting a growth rate (CAGR) of 7.47% during 2022-2027. A biological safety cabinet (BSC), or microbiological safety cabinet, is an enclosed, ventilated laboratory workspace designed to protect the surrounding environment and personnel from pathogenic microorganisms. It comprises high-efficiency particulate absorbing (HEPA) filtration systems that decontaminate the air flowing out of the cabinet. Depending on the level of product protection, biosafety cabinets are classified into I, II and III classes. Amongst these, class I and II cabinets are primarily used for the safe manipulation of moderate- and high-risk microorganisms. On the other hand, class III BSCs are ideal for working with hazardous agents with biosafety levels 3 and 4. These workspaces can be customized according to the user preference to obtain optimum control over quality and minimize contamination risks. Request for a free sample copy of this report: https://www.imarcgroup.com/biological-safety-cabinet-market/requestsample Market Trends: The BSC market growth is majorly being driven by the increasing risks of communicable diseases and the sudden outbreak of coronavirus disease (COVID-19) across the globe. Additionally, significant expansion in the biotechnology and life sciences sectors is further propelling the market growth. Besides this, the rising expenditure in the improvement of healthcare infrastructure and numerous investments in research and development (R&D) by pharmaceutical and biopharmaceutical companies are positively influencing the market growth. Moreover, diagnostic labs and pharmaceutical manufacturers are increasingly utilizing BSCs to maintain the microbiological quality of drugs, which is acting as a growth-inducing factor for the market. Furthermore, the introduction of advanced product variants with improved construction, airflow pattern, velocities and exhaust systems is creating a positive outlook for the market. Breakup by Type:
- Class I
- Class II
- Class II Type A
- Class II Type B
- Class III
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostic and Testing Laboratories
- Academic and Research Institutions
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
- Air Science
- Berner International
- BIOBASE
- Esco Micro Pte Ltd.
- EUROCLONE SPA (AddLife Development AB)
- Germfree Laboratories
- Kewaunee Scientific Corporation
- Labconco
- NuAire (Polypipe)
- The Baker Company, Inc.
- Thermo Fisher Scientific Inc.